50.0% of TP53-associated lung cancers were squamous cell carcinoma (Table 2) and 20.0% of TP53 mutations associated with ‘high differentiation’ cancers and 25.9% of TP53 mutations were ‘mid differentiation’ cancers (Table 3). The gene discussed is TP53; the disease is cancer.